Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Seizures as an adverse drug reaction after therapeutic dose of vincristine.

Mahapatra M, Kumar R, Choudhry VP.

Ann Hematol. 2007 Feb;86(2):153-4. Epub 2006 Oct 10. No abstract available.

PMID:
17031686
2.

Fatal myeloencephalopathy due to intrathecal vincristine administration.

al Fawaz IM.

Ann Trop Paediatr. 1992;12(3):339-42. Review.

PMID:
1280054
3.

Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia.

Bacon LC, Barnett MJ, Abou Mourad YR.

Ann Hematol. 2012 Jun;91(6):971-2. doi: 10.1007/s00277-011-1348-3. No abstract available.

PMID:
21976108
4.

Bilateral vocal cord paralysis following treatment with vincristine.

Naithani R, Dolai TK, Kumar R.

Indian Pediatr. 2009 Jan;46(1):68-9.

5.

Bilateral vocal fold paralysis following treatment with vincristine.

Praveen CV, De Lord CF.

J Laryngol Otol. 2006 May;120(5):423. Review. No abstract available.

PMID:
16696885
6.

Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.

Fioredda F, Micalizzi C, Lanciotti M, Dufour C, Lamba LD, Fiocchi I.

Med Pediatr Oncol. 2002 Aug;39(2):141-2. No abstract available.

PMID:
12116067
7.

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

Jabbour E, O'Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F, Cabanillas M, Thomas DA.

Blood. 2007 Apr 15;109(8):3214-8. Epub 2007 Jan 5.

PMID:
17209054
8.

Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.

Renbarger JL, McCammack KC, Rouse CE, Hall SD.

Pediatr Blood Cancer. 2008 Apr;50(4):769-71.

PMID:
18085684
9.

Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.

Riga M, Korres S, Psarommatis I, Varvutsi M, Giotakis I, Papadas T, Ferekidis E, Apostolopoulos N.

Otol Neurotol. 2007 Feb;28(2):208-12.

PMID:
17255889
10.

Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.

Harnicar S, Adel N, Jurcic J.

J Oncol Pharm Pract. 2009 Sep;15(3):175-82. doi: 10.1177/1078155208101959. Epub 2009 Mar 12.

PMID:
19282418
11.

[Inappropriate ADH syndrome and other toxic effects in the course of childhood ALL treated with vincristine].

Indiano JM, González A, Oria de Rueda O, Sánchez E.

An Esp Pediatr. 1988 Oct;29 Suppl 34:155-6. Spanish. No abstract available.

PMID:
3214029
12.

[Encephalopathy appearing during treatment with vincristine. Anatomo-clinical case].

Rosemberg S.

Arch Fr Pediatr. 1974 Apr;31(4):391-8. French. No abstract available.

PMID:
4848646
13.

Vincristine-induced bilateral vocal cord paralysis in children.

Ahmed A, Williams D, Nicholson J.

Pediatr Blood Cancer. 2007 Feb;48(2):248. No abstract available.

PMID:
16609949
14.

[Isolated unilateral cranial nerve palsy during childhood acute lymphoblastic leukemia treatment: What does it mean?].

Saumet L, Haouy S, Daien V, Hillaire-Buys D, Roessler J, Sirvent N.

Arch Pediatr. 2016 Apr;23(4):415-6. doi: 10.1016/j.arcped.2016.01.008. Epub 2016 Mar 8. French. No abstract available.

PMID:
26968305
15.

A new formulation of vincristine for acute lymphoblastic leukemia.

Heffner L Jr.

Clin Adv Hematol Oncol. 2011 Apr;9(4):314-6. No abstract available.

PMID:
21558991
16.

Carbone PP, Bono V, Frei E III, Brindley CO. Clinical studies with vincristine. Blood. 1963;21(5):640-647.

[No authors listed]

Blood. 2016 Jun 16;127(24):2941. doi: 10.1182/blood-2016-04-713453. No abstract available.

PMID:
27313320
17.

[Cerebral convulsions and acute psychosyndrome following vincristine therapy].

Von Mittler U, Fischer HU, Schütze I, Jaenecke J.

Kinderarztl Prax. 1974 Sep;42(9):403-7. German. No abstract available.

PMID:
4459498
19.

Vincristine induced unilateral ptosis.

Dejan S, Dragana B, Ivana P, Borivoje B, Marko P.

J Pediatr Hematol Oncol. 2009 Jun;31(6):463. doi: 10.1097/MPH.0b013e3181a7153e. No abstract available.

PMID:
19648799
20.

Vincristine-itraconazole interaction: cause for increasing concern.

Sathiapalan RK, Al-Nasser A, El-Solh H, Al-Mohsen I, Al-Jumaah S.

J Pediatr Hematol Oncol. 2002 Oct;24(7):591. No abstract available.

PMID:
12368705

Supplemental Content

Support Center